Investigating the role of microRNA22-3p in Alzheimer's disease and tauopathies
Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis
This study is looking at how a tiny molecule called miRNA22-3p affects the development of Alzheimer's disease and similar conditions by checking brain samples from mice and people, which could help find new ways to treat these diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10881912 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific microRNA, miRNA22-3p, influences the development of Alzheimer's disease and related tauopathies. By examining brain tissues from both mouse models and human patients, the study aims to identify the mechanisms that lead to the accumulation of tau protein, a hallmark of these conditions. The researchers will analyze changes in microRNA levels over time to determine their relationship with disease progression. This could help in uncovering potential targets for new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related tauopathies, particularly those in the early stages of the disease.
Not a fit: Patients with other forms of dementia that do not involve tau pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventative measures or treatments for Alzheimer's disease and related disorders.
How similar studies have performed: Previous research has shown that targeting microRNAs can influence neurodegenerative processes, suggesting that this approach may hold promise for similar breakthroughs.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Pratico, Domenico — Temple Univ of the Commonwealth
- Study coordinator: Pratico, Domenico
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.